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Objectives: The single nucleotide polymorphisms (SNPs) in the FADS1/FADS2
gene cluster have been associated with serum lipid levels and the incidence of
coronary artery disease (CAD), but the results are inconsistent. It is unknown
whether these SNPs in this gene cluster are associated with ischemic stroke (IS).
Therefore, the present study was undertaken to evaluate the associations between
two SNPs (rs174546 and rs174601) and serum lipid levels, as well as the risk of IS
or CAD.
Methods: A total of 534 patients with CAD, 553 patients with IS and 582 healthy
controls were recruited in this study. The patients with is received strict neurological
examination and brain magnetic resonance imaging scan. It was diagnosed according
to the International Classiﬁcation of Diseases (9th Revision). Coronary angiography
was performed in patients with CAD. CAD was deﬁned as signiﬁcant coronary ste-
nosis (> 50%) in at least either one of the three main coronary arteries or their major
branches (branch diameter>2 mm). Subjects with a history of hematologic, neoplastic,
renal, liver, thyroid, autoimmune diseases and type I diabetes mellitus were excluded.
Genotypes of the rs174546 and rs174601 SNPs were determined by Snapshot tech-
nology platform.
Results: The genotype distribution was concordant with the Hardy-Weinberg pro-
portions in both patients and controls. There were signiﬁcant differences in allelic
frequency and genotype distribution between controls and IS or CAD patients
(P<0.05), the TT genotypic frequency of the two SNPs was higher in IS or CAD
patients than in controls (P<0.05). The rs174546 and rs174601 C allele carriers
conferred a reduced risk for IS and CAD (rs174546: OR ¼ 0.62, 95% CI ¼ 0.48-0.80
for IS and OR ¼ 0.57, 95% CI ¼ 0.44-0.75 for CAD; rs174601: OR ¼ 0.61, 95% CI
¼ 0.48-0.79 for IS and OR ¼ 0.54, 95% CI ¼ 0.41-0.70 for CAD; respectively). The
rs174546 SNP was in strong LD with rs174601 (D’ ¼ 0.951; r2 ¼ 0.860). Two
common haplotypes (frequency>3%) derived from the two SNPs accounted for above
90% haplotype variations. Among these two common haplotypes, the haplotype of C-
C (rs174546-rs174601) was also associated with a reduced risk for IS and CAD (OR
¼ 0.76, 95% CI ¼ 0.63-0.91 for IS and OR ¼ 0.72, 95% CI ¼ 0.60-0.87 for CAD;
respectively), whereas the haplotype of T-T (rs174546-rs174601) was associated with
an increased risk for IS and CAD (OR ¼ 1.32, 95% CI ¼ 1.10-1.59 for IS and OR ¼
1.18, 95% CI ¼ 0.98-1.41 for CAD; respectively). There was no signiﬁcant associ-
ation between genotypes and serum lipid levels. There were no signiﬁcant effects of
the rs174546 or rs174601 SNPs on angiographic severity of CAD in different genetic
models (P>0.05).
Conclusions: The present study suggests that the SNPs of rs174546 and rs174601 in
the FADS1/FADS2 gene cluster are associated with the risk of IS or CAD, but not
with serum lipid parameters.
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Objectives: To investigate circulating microRNA (miRNA) expression in apolipo-
protein E (apoE) knockout mice (apoE-/-), and to validate these miRNAs in human
coronary artery disease (CAD).
Methods: Pooled plasma from 10 apoE-/- mice and from 10 healthy C57BL/6 (B6)
mice was used to perform the microarray analysis.
Results: MiR-34a, -21, -23a, -30a, and -106b were differentially expressed in apoE-/-
mice. These expression changes of the miRNAs were conﬁrmed by real-time quan-
titative reverse-transcription PCR (qRT-PCR) in apoE-/- mice. Then, miR-34a, -21,
-23a, -30a, and -106b were detected in the plasma of 32 patients with CAD and of 20
healthy controls. Only miR-34a, -21 and -23a were signiﬁcantly differentially
expressed in the plasma of CAD patients (all P<0.01).
Conclusions: MiRNA34a, miRNA21 and miRNA23a were elevated in CAD patients.
These miRNAs might serve as biomarkers of CAD development and progression.
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Objectives: This study was performed to examine the effect of dobutamine stress real
time three-dimensional echocardiography (DS-RT3DE) on ischemic mitral regurgi-
tation (IMR) secondary to coronary artery disease and to test the hypothesis that IMR
and left ventricular (LV) pump function change differently in different stress state in
patients with coronary artery response.
Methods: DS-RT3DE was performed in 90 consecutive patients with suspected or
known coronary artery disease. Three-dimensional echocardiography was used to
determine the change in left ventricular volume and mitral regurgitation at baseline
and every dobutamine infusion dose (5, 10, 20, 30, 40, 50 mg/kg.min for 3 minutes at
each dose). The LV volume and ejection fraction, LV systolic desynchronization, and
mitral regurgitation color ﬂow Doppler contracta area were quantiﬁed. Patients were
assigned to three groups according to IMR contracta area variation during the stressC118 JACC Vol 64/16/Suppl C j October 16–1procedure, group I included patients who IMR decreased in all stress states, group II
included patients who IMR increased in some states and decreased in other states,
group III included patients who IMR increased in all states.
Results: All patients achieved 20ug/kg$min dose, 82 patients achieved 30ug/kg$min
dose, 64 patients achieved 40ug/kg$min dose, only 39 patients achieved 50ug/kg$min
dose. Atropine was administered in 14 patients (16%). There was no severe adverse
event occurred during the stress procedure in this study. In group I (42 patients), LV
end-diastolic and end-systolic volume decreased and ejection fraction increased with
dobutamine dose increasing, and achieved peak value at 50ug/kg.min dose (P<0.05).
In group II (31 patients), LV end-diastolic and end-systolic volume and ejection
fraction changed same as group I (P<0.05), but the extent less than group I. In group
III (17 patients), LV end-diastolic and end-systolic volume increased and ejection
fraction decreased in low dose (P<0.05), whereas no signiﬁcant change in high dose
(P>0.05). LV synchronism improved in all groups, and group I had better perfor-
mance than other groups (P<0.05).
Conclusions: Dobutamine stress testing, in combination with three-dimensional
echocardiography, is an effective method to obtaining accurate information in the
assessment of the behavior of IMR and LV function. Our study indicates IMR
decreased with LV pump function and synchronisms improving in most patients,
it also suggest that the heart still has considerable hibernate, stunning myocar-
dium. Otherwise, if the IMR keep increase during whole stress procedure, it
proposes the coronary artery has severe stenosis and less viable myocardium.
These ﬁndings may helpful to make up appropriate IMR therapy plan in patients
with ischemic heart disease. We hypotheses only the patients with worsen IMR in
DS-RT3DE need to take mitral valve repair or replacement together with coro-
nary artery bypass grafting operation, and we will try to approve it in future
studies.
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Objectives: Percutaneous coronary intervention (PCI) through transradial approach
(TRA) has shown great effectiveness among unselected patients. However, very few
studies have compared the short and median outcomes between TRA and transfemoral
approach (TFA) for diagnostic angiography or intervention in post-coronary artery
bypass graft (CABG) patients.
Methods: A total of 404 post-CABG patients who referred for graft angiography or
intervention were retrospectively included from June 1, 2006 to April 30, 2011. The
primary endpoint was deﬁned as in-hospital net adverse clinical events (NACE),
which included all-cause death, myocardial infarction, stroke, repeat revascularization
and major bleeding. The secondary endpoint was deﬁned as 1 year major adverse
cardiovascular events (MACE), which included all-cause death, MI or repeat
revascularization.
Results: The incidence rates of the primary endpoint (2.7% vs. 2.7%, P¼1.00) and the
secondary endpoint (11.5% vs. 12%, P¼0.88) were similar between TRA and TFA.
TRA was associated with similar procedure time (33.2325.39 vs. 29.6719.87,
P¼0.18) and contrast volume (157.1189.65 vs. 175.80111.35, P¼0.09) compared
with TFA. Signiﬁcant reduction of access site-related bleeding and post-procedure
stay was detected in the TRA group (P<0.05). In patients who had undergone ad hoc
intervention of the grafts, the contrast volume was higher in the TFA group
(156.0069.70 ml vs. 198.38132.89 ml, P¼0.05). The adjusted rates of in-hospital
NACE and 1 year MACE were similar between TRA and TFA, and TRA was an
independent predictor of BARC2 bleeding.
Conclusions: Compared with TFA, TRA showed the same effectiveness in regard to
the in-hospital and 1 year major outcomes in post-CABG patients undergoing PCI.
TRA was also associated with reduced rate of extra bleeding and length of hospital
stay. For patients undergoing the grafts intervention, the contrast volume was
signiﬁcantly reduced by TRA.
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Objectives: Inﬂammatory response has observed in myocardial infarction (MI).
Rheumatoid arthritis (RA) is a kind of systemic inﬂammatory disease and studies
before have proved MI happened more frequently than general people. This research
had been done to explore the risk factors related to MI in RA patients.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
Methods: This retrospective study included 106 consecutive patients with RA in
Fuwai cardiovascular disease hospital between January 2010 and January 2012, all of
them had been conﬁrmed as coronary disease by coronary angiography. At this
sampling 46 RA patients were developed MI. The control group includes 60 subjects
who were free of MI. The characteristics of both groups were compared including
demographics, traditional cardiovascular risks and laboratory ﬁndings. Cases of MI
and controls were compared by disease activity variables and risk factors using the
student’s t test (for continuous variables) or the c2test (for dichotomous variables).
Variables that had a P value of <0.2 in the single factor logistic regression were
entered into a multivariate model.
Results: There were no signiﬁcant differences about demographics, traditional car-
diovascular between MI group and control group, such as age, gender, Body Mass
Index (BMI), the percentage of hypertension (HT), diabetes mellitus (DM), hyper-
lipidaemia (HLP) and Smoking. MI group showed increased Erythrocyte Sedimen-
tation Rate (ESR) (P¼0.014),C-reactive protein (CRP) (P¼0.000) and creatinine
(P¼0.024) levels than control group. The result of univariate logistic’s regression
demonstrated that ESR (P¼0.009), CRP (P¼0.022), CR (P¼0.030), lipoproteins (LP-
a) (P¼0.097) and high-sensitivity C-reactive protein (Hs-CRP) (P¼0.009) are asso-
ciated with increased risk of MI in RA. The result of analysis of multivariate logistic’s
regression showed that ESR [OR 95% CI 1.024 (1.007-1.043), P¼0.007] was an
independent risk factor of MI in RA patients.
Conclusions: Patients with RA who developed MI had similar traditional cardio-
vascular risk factors compared to RA patients without MI, but had signiﬁcant dif-
ferences in inﬂammatory indexes. Inﬂammation may accelerate atherogenesis and
have an excess risk of MI in RA patient with cardiovascular disease.
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Objectives: Nebivolol, third-generation b-blocker, may activate b3-adrenergic re-
ceptor (AR), which has been emerged as a novel and potential therapeutic targets for
cardiovascular diseases. However, it is not known whether nebivolol administration
plays a cardioprotective effect against myocardial infarction (MI) injury. Therefore,
the present study was designed to clarify the effects of nebivolol on MI injury and to
elucidate the underlying mechanism.
Methods: MI model was constructed by left anterior descending (LAD) artery liga-
tion. Nebivolol, SR59230A (SR), Nitro-L-arginine methylester (L-NAME) or vehicle
was administered one day after MI operation. Cardiac function was monitored by
echocardiography. Moreover, the ﬁbrosis and the apoptosis of myocardium were
assessed by Masson’s trichrome stain and TUNEL assay respectively.
Results: Nebivolol administration reduced scar area by 68% compared with MI group
(P<0.05). Meanwhile, nebivolol also decreased the myocardial apoptosis and
improved the heart function after MI (P<0.05 vs. MI). These effects were associated
with increased b3-AR expression. Furthermore, nebivolol treatment signiﬁcantly
increased the phosphorylation of endothelial NOS (eNOS) and the expression of
neuronal NOS (nNOS). Conversely, the cardiac protective effects of nebivolol were
abolished by SR and L-NAME.
Conclusions: These results indicate that nebivolol protects against MI injury.
Furthermore, the cardioprotective effects of nebivolol may be mediated by b3-AR-
eNOS/nNOS pathway.
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Objectives: The association of single nucleotide polymorphisms (SNPs) in the
glucokinase (hexokinase 4) regulator (GCKR) gene and serum lipid levels is incon-
sistent. The goal of this study was to test the association between polymorphisms in
the GCKR gene and serum lipid levels, and the risk of coronary artery disease (CAD)
and ischemic stroke (IS) in the Guangxi Han population and to identify the potential
mechanism.
Methods: Genotyping of the GCKR rs1260326 and rs8179206 SNPs in 1736 unre-
lated subjects (CAD, 584; IS, 555; and healthy controls; 597) was performed by
Snapshot technology platform. Coronary angiography was performed in patients with
CAD. CAD was deﬁned as signiﬁcant coronary stenosis (> 50%) in at least either one
of the three main coronary arteries or their major branches (branch diameter>2 mm).
The patients with is received strict neurological examination and brain magnetic
resonance imaging scan. It was diagnosed according to the International Classiﬁcation
of Diseases (9th Revision).
Results: The genotypic and allelic frequencies of rs1260326 and rs8179206 SNPs
were not signiﬁcantly different between controls and CAD or IS patients, or between
CAD and IS patients (P>0.05 for all). The subjects with TT genotype of rs1260326
SNP had higher serum low-density lipoprotein cholesterol (LDL-C) levels in controlsJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cand higher triglyceride (TG) levels in CAD patients than the subjects with CC and CT
genotypes (P<0.05) after adjustment of age, sex, body mass index, blood pressure,
alcohol consumption, and cigarette smoking. But this association was not found in the
IS patients.
Conclusions: The present study shows that the TT genotype of GCKR rs1260326
SNP is associated with high LDL-C levels in controls and high TG levels in the CAD
patients.
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Objectives: To assess the relationship between brachial-ankle pulse wave velocity
and left ventricular diastolic function of hospitalized patients in department of
cardiology.
Methods: Six hundred ﬁfty-two patients in department of cardiology in Peking
University First Hospital were enrolled in the study. They were hospitalized
because of cardiovascular diseases during Nov 2012 to Oct 2013. The clinical
information and echocardiography were collected. The brachial-ankle pulse wave
velocity was measured noninvasively. The patients were divided into four groups
according to left ventricular diastolic function: group of normal diastolic
function deﬁned as E/A0.8, E/ E’8; group of mild diastolic dysfunction deﬁned
as E/A<0.8, E/E’8; group of moderate diastolic dysfunction deﬁned as 0.8E/
A1.5, 8<E/E’<13; group of severe diastolic dysfunction deﬁned as E/A2.0, E/
E’ 13. baPWV were compared between four groups. The relationship between left
ventricular diastolic function and baPWV was analyzed using spearman method.
Logistic regression model was used to correction the factors inﬂuencing LV dia-
stolic function.
Results: (1) The baPWV were 1403.09256.61 cm/s, 1631.03357.67 cm/s,
1641.02605.50 cm/s and 1718.85350.53 cm/s in normal diastolic function group,
mild diastolic dysfunction group, moderate diastolic dysfunction group and severe
diastolic dysfunction group separately. The baPWV rise with left ventricular diastolic
function decreased in four groups and there was statistically signiﬁcant (P<0.001). (2)
The baPWV was signiﬁcantly negatively correlated with E/A ratio (r¼-0.257,
P<0.001), and was signiﬁcantly positively correlated with E/E’ ratio (r¼0.249,
P<0.001). (2) Multiple logistic regression analysis showed: baPWV1400 cm/s is a
danger factor to left ventricular diastolic dysfunction, the RR values were 1.93 (95%
CI 1.09-3.44, P¼0.03).
Conclusions: The baPWV is correlated with left ventricular diastolic dysfunction, and
it can be a screening method for high risk group with left ventricular diastolic
dysfunction.
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Objectives: To evaluate the predictive value of both CYP2C19 genotype and
platelet function phenotype grouping methods in clinical outcomes and bleeding
events of patients receiving clopidogrel underwent percutaneous coronary inter-
vention (PCI).
Methods: Coronary heart disease (CHD) patients administered in Fuwai hospital
underwent elective PCI and received coronary stent implantation were prospectively
enrolled during October 2012 to May 2013, who were treated with a 300-mg bolus
of clopidogrel before PCI and a 75-mg maintenance dose once daily for 1 year
thereafter, in combination with a 100-mg maintenance dose once daily of chronic
aspirin therapy. Patients were assigned into groups by genotype of CYP2C19
(extensive metabolizers, intermediate metabolizers, and poor metabolizers) and
phenotype of platelet function (clopidogrel responders, semi-responders, and non-
responders). The rates of major adverse cardiovascular events, cardiovascular
symptom events, and bleeding events were recorded during a follow-up period until
6 months after the last patient ﬁrst visit and compared among the groups deﬁned
previously.
Results: 380 patients received coronary stent implantation were enrolled in this
study, including 157 (41.3%) clopidogrel extensive metabolizers, 176 (46.3%) in-
termediate metabolizers, and 47 (12.4%) poor metabolizers according to the genotype
grouping; 98 (25.8%) were responders to clopidogrel, 149 (39.2%) were semi-re-
sponders, and 133 (35.0%) were non-responders according to the phenotype
grouping. The highest cardiovascular symptom events rate was observed in the poor
metabolizers (34.0%) as compared to the intermediate metabolizers (19.1%,
HR¼2.126, 95% CI 1.131-3.997, P¼0.019) and the extensive metabolizers (15.4%,
HR¼2.772, 95% CI 1.359-5.655, P¼0.005) when grouping by the CYP2C19
genotype, without a statistical difference of the major adverse cardiovascular events
rate or bleeding events rate. The highest bleeding events rate was observed in the
clopidogrel responders (32.7%) as compared to the semi-responders (19.0%,ardiovascular Disease Clinical Research C119
